Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Germed Farmacêutica is a prominent Brazilian pharmaceutical company specializing in the development, manufacturing, and commercialization of generic and branded generic medicines. Founded in 2002 and headquartered in Hortolândia, São Paulo, the company is a key subsidiary of Grupo NC, one of Brazil's largest pharmaceutical conglomerates. Germed maintains a diverse portfolio covering numerous therapeutic areas, including cardiology, dermatology, and central nervous system disorders. The company is recognized for its commitment to providing high-quality, affordable healthcare solutions and has expanded its footprint internationally, notably in Portugal. Its operations are supported by advanced manufacturing facilities that adhere to rigorous Good Manufacturing Practice (GMP) standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Germed Farmacêutica.